What is Shukra Pharmaceuticals Price-to-Operating-Cash-Flow?
As of today (2024-05-24), Shukra Pharmaceuticals's share price is ₹111.29.
Shukra Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00. Hence, Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:
BOM:524632'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 242.86
Current: 23.61
During the past 13 years, Shukra Pharmaceuticals's highest Price-to-Operating-Cash-Flow Ratio was 242.86. The lowest was 0.00. And the median was 0.00.
Shukra Pharmaceuticals's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 128.30% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 124.80% per year.
During the past 13 years, Shukra Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 429.30% per year. The lowest was -137.40% per year. And the median was 53.30% per year.
Shukra Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shukra Pharmaceuticals Price-to-Operating-Cash-Flow Chart
|
Shukra Pharmaceuticals Annual Data
|
|
Trend |
Mar14 |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
22.11 |
6.14 |
12.94 |
0.25 |
2.49 |
|
Shukra Pharmaceuticals Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
2.49 |
- |
- |
- |
Competitive Comparison of Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.
Shukra Pharmaceuticals Price-to-Operating-Cash-Flow Calculation
Shukra Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 111.29 | / | 0 |
| = | |
Shukra Pharmaceuticals's Share Price of today is ₹111.29.
Shukra Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Shukra Pharmaceuticals (BOM:524632) Business Description
Traded in Other Exchanges
N/A
Address
Judges Bunglow Road, Bodakdev, 3rd Floor, Veer House, Opposite WIAA Office, Ahmedabad, GJ, IND, 380054
Shukra Pharmaceuticals Ltd is engaged in the business of manufacturing and trading pharmaceutical products. The company markets its products in India and international markets. The company has two operating segments; pharmaceutical and Laboratory. Its product portfolio includes antibiotics, antibiotics, quinolones, macrolides, anti-bacterial, anti-fungal, anti-malarial, anti-viral, antiprotozoal, anti-anthelmintic, anti-depressant, anti-manic, anti-emetic, beta-blockers, analgesic, muscle relaxants, anti-tuberculosis, vitamin products, anti-allergic, corticosteroids, hyper and hypoglycemic, and others. It exports its products to Australia, Uganda, Kenya, the United Kingdom, Sri Lanka, Mauritius, and the Republic of Yemen.
Shukra Pharmaceuticals (BOM:524632) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524632 has been successfully added to your